The benefit of adjuvant radiotherapy in high-grade nonmetastatic retroperitoneal soft tissue sarcoma: A SEER analysis
American Journal of Clinical Oncology Mar 06, 2018
Bates JE, et al. - The efficacy of adjuvant radiotherapy (RT) in high-grade retroperitoneal sarcoma (RPS) given the known benefits of RT for local control and overall survival (OS) in patients with high-grade extremity soft tissue sarcoma was determined. Improved OS was reported in high-grade RPS patients who received post-operative RT. Adjuvant RT should be considered for all patients with high-grade RPS.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries